Drug name - Tyrvaya

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11224598 OYSTER POINT PHARMA Methods of increasing lacrimal proteins Oct, 2035

(13 years from now)

US10456396 OYSTER POINT PHARMA Dry eye treatments Oct, 2035

(13 years from now)

US9597284 OYSTER POINT PHARMA Dry eye treatments Oct, 2035

(13 years from now)

US9532944 OYSTER POINT PHARMA Methods of improving ocular discomfort Oct, 2035

(13 years from now)

US9504644 OYSTER POINT PHARMA Methods of increasing tear production Oct, 2035

(13 years from now)

US9504645 OYSTER POINT PHARMA Pharmaceutical formulations for treating ocular conditions Oct, 2035

(13 years from now)

Drugs and Companies using VARENICLINE TARTRATE ingredient

Treatment: Treatment of the signs and symptoms of dry eye disease (ded)

Dosage: SOLUTION;NASAL

More Information on Dosage
Strength Dosage Availability
EQ 0.03MG BASE/SPRAY SOLUTION;NASAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.